Insider Trading & Ownership of Keith A. Goldan

Location
Conshohocken, PA
Summary
The estimated net worth of Keith A. Goldan is at least $5,673,377 dollars as of 07 Apr 2026. Keith A. Goldan is the Chief Financial Officer of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $5.36M. Keith A. Goldan is the Chief Financial Officer of OptiNose, Inc. and owns shares of OptiNose, Inc. stock worth about $163K. Keith A. Goldan is the Director of ABEONA THERAPEUTICS INC. and owns shares of ABEONA THERAPEUTICS INC. (ABEO) stock worth about $146.7K.
Signature
/s/ Joseph Vazzano, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Keith A. Goldan and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Keith A. Goldan has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,673,377.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Syndax Pharmaceuticals Inc ($5,363,681).
  • Past-year value change for that position: -$126,670.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Keith A. Goldan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Chief Financial Officer $5,363,681 -$126,670 -2.3% 09 Feb 2026
OPTN OptiNose, Inc. Chief Financial Officer $162,985 16 Mar 2022
ABEO ABEONA THERAPEUTICS INC. Director $146,711 01 Apr 2026

Insider Transactions Reported by Keith A. Goldan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .